ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...

Alpha-gal syndrome was discovered because of unexpected severe drug reactions, including anaphylaxis, in some patients who took cetuximab, a cancer drug. A 2008 study found antibodies to alpha-gal ...

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

(Image Credits: Reuters) The U.S. Food and Drug Administration (FDA) has issued a warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone ...

For example, if the control patient has a history of a cutaneous adverse drug reaction after ingesting acetaminophen and clindamycin and this reaction is confirmed either by skin tests or repeat ...

Concerned over the widely used life-saving beta blocker drugs causing adverse drug reactions, the government’s Indian Pharmacopoeia Commission (IPC) has issued an alert about the same.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

For more information about injection site reaction and headache, see “Side effect specifics.” Note: After the FDA approves a drug, it tracks and reviews side effects of the medication.